Earnings History for AstraZeneca (AZN)
|
Expand Research on AZN
| Next EPS Date | 10/27/11 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -10.1% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -0.8% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
1/31/13  |
Q412 | $1.56 | $1.41 | +$0.15 | $7.28B | $7.17B | N/A / N/A | = | +2.3% | Details | |
| 10/25/12 |
Q312 | $0.51 | $1.47 | -$0.96 | $6.68B | $6.61B | N/A / N/A | N/A | +10.6% | Details | |
| 7/26/12 |
Q212 | $1.53 | $1.36 | +$0.17 | $6.66B | $6.78B | $1.36 / $6.83B | N/A | +12.2% | Details | |
| 4/26/12 |
Q112 | $1.81 | $1.78 | +$0.03 | $7.35B | $7.85B | $1.89 / $8.03B | N/A | +11% | Details | |
| 2/2/12 | Q411 | $1.16 | $1.56 | -$0.40 | $8.66B | $8.59B | N/A / N/A | N/A | +4.9% | Details | |
| 10/27/11 | Q311 | N/A | $1.68 | N/A | N/A | $8.25B | $1.76 / $8.37B |  |
N/A | N/A | |
| 7/28/11 |
 |
Q211 | $1.73 | $1.80 | -$0.07 | $8.43M | $8.19B | N/A / N/A | |
+4.4% | Details |
| 4/28/11 |
Q111 | $2.23 | $2.00 | +$0.23 | $8.29B | $8.43B | N/A / N/A | |
-1.2% | Details |
